Publication: Neuro-oncology in 2013: improving outcome in newly diagnosed malignant glioma
Neuro-oncology in 2013: improving outcome in newly diagnosed malignant glioma
Date
Date
Date
Citations
Weller, M., & Wick, W. (2014). Neuro-oncology in 2013: improving outcome in newly diagnosed malignant glioma. Nature Reviews. Neurology, 10, 68–70. https://doi.org/10.1038/nrneurol.2013.268
Abstract
Abstract
Abstract
In 2013, two discoveries—that alkylating agent chemotherapy prolongs survival when added to radiotherapy for patients with anaplastic oligodendroglial tumours with 1p19q codeletion, and that bevacizumab prolongs progression-free survival in patients with newly diagnosed glioblastoma—have dominated debate in neuro-oncology. These findings could help to define new standards of care in malignant glioma.
Additional indexing
Creators (Authors)
- Weller, M
- Wick, W
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Citations
Weller, M., & Wick, W. (2014). Neuro-oncology in 2013: improving outcome in newly diagnosed malignant glioma. Nature Reviews. Neurology, 10, 68–70. https://doi.org/10.1038/nrneurol.2013.268
